Study Review – Azacitidine and venetoclax in untreated AML

As part of our ongoing aim to bring you reports of interesting new studies, we have added a review of a study looking at Azacitidine and Venetoclax in previously untreated acute myeloid leukaemia.

Independent expert commentary is provided by Professor Paula Marlton, the Head of Leukaemia and Deputy Director of Haematology at the Princess Alexandra Hospital in Brisbane and School of Clinical Medicine, University of Queensland.

Please login below to download this issue (PDF)

Subscribe